Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
The Iowa Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal document that outlines the terms and conditions governing the licensing rights of Gentling, Inc. in relation to any collateral developed during their collaboration with The University of North Texas Health Science Center. This agreement ensures that all parties involved are protected and that the intellectual property rights and commercialization rights are clearly defined. One type of Iowa Collateral License Agreement that may exist between Gentling, Inc. and The University of North Texas Health Science Center is the Exclusive Collateral License Agreement. This type of agreement grants Gentling, Inc. exclusive rights to commercially exploit and develop the collateral developed through their collaboration with The University of North Texas Health Science Center. This means that no other entity will be granted similar rights, giving Gentling, Inc. a competitive advantage in the market. Another type of Iowa Collateral License Agreement that could be in place is the Non-Exclusive Collateral License Agreement. In this scenario, multiple entities, including Gentling, Inc., may be granted non-exclusive rights to the collateral. This allows for broader commercialization possibilities as multiple parties can independently develop and market the collateral, broadening its reach and potential impact. The Iowa Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center will cover aspects such as the scope of the license, the duration of the license, any financial considerations, and obligations of both parties. It will also address issues related to intellectual property rights, confidentiality, indemnification, and dispute resolution. By entering into this agreement, both Gentling, Inc. and The University of North Texas Health Science Center can ensure that their interests are protected and that any collateral developed through their partnership can be effectively utilized for the benefit of both parties and further advancements in health science.
The Iowa Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legal document that outlines the terms and conditions governing the licensing rights of Gentling, Inc. in relation to any collateral developed during their collaboration with The University of North Texas Health Science Center. This agreement ensures that all parties involved are protected and that the intellectual property rights and commercialization rights are clearly defined. One type of Iowa Collateral License Agreement that may exist between Gentling, Inc. and The University of North Texas Health Science Center is the Exclusive Collateral License Agreement. This type of agreement grants Gentling, Inc. exclusive rights to commercially exploit and develop the collateral developed through their collaboration with The University of North Texas Health Science Center. This means that no other entity will be granted similar rights, giving Gentling, Inc. a competitive advantage in the market. Another type of Iowa Collateral License Agreement that could be in place is the Non-Exclusive Collateral License Agreement. In this scenario, multiple entities, including Gentling, Inc., may be granted non-exclusive rights to the collateral. This allows for broader commercialization possibilities as multiple parties can independently develop and market the collateral, broadening its reach and potential impact. The Iowa Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center will cover aspects such as the scope of the license, the duration of the license, any financial considerations, and obligations of both parties. It will also address issues related to intellectual property rights, confidentiality, indemnification, and dispute resolution. By entering into this agreement, both Gentling, Inc. and The University of North Texas Health Science Center can ensure that their interests are protected and that any collateral developed through their partnership can be effectively utilized for the benefit of both parties and further advancements in health science.